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Abstract
Objective—Polymorphisms of the glucocorticoid receptor (GCR) gene are associated with
outcome and corticosteroid responsiveness among patients with inflammatory disorders. We
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conducted a candidate gene association study to test the hypothesis that these polymorphisms are
associated with outcome and corticosteroid responsiveness among children with septic shock.
Design—We genotyped 482 children with septic shock for the presence of two GCR
polymorphisms (rs56149945 and rs41423247) associated with increased sensitivity and one GCR
polymorphism (rs6198) associated with decreased sensitivity to corticosteroids. The primary
outcome variable was complicated course, defined as 28-day mortality or the persistence of two or
more organ failures seven days after a septic shock diagnosis. We used logistic regression to test
for an association between corticosteroid exposure and outcome, within genotype group, and
adjusted for illness severity.
Setting—Multiple pediatric intensive care units in the United States.
Interventions—Standard care.
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Measurements and Main Results—There were no differences in outcome when comparing
the various genotype groups. Among patients homozygous for the wild type GCR allele,
corticosteroids were independently associated with increased odds of complicated course (O.R.
2.30; 95% C.I. 1.01 to 5.21; p = 0.047).
Conclusions—Based on these GCR polymorphisms, we could not detect a beneficial effect of
corticosteroids among any genotype group. Among children homozygous for the wild type allele,
corticosteroids were independently associated with increased odds of poor outcome.
Keywords
sepsis; polymorphisms; outcome; corticosteroids; organ failure
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INTRODUCTION
The role of corticosteroids for pediatric septic shock remains controversial. Corticosteroids
are widely prescribed for children with septic shock, particularly those perceived to have
refractory shock, based on guidelines and long standing anecdotal experiences [1-3]. Yet,
there are no large, randomized trials demonstrating efficacy and several observational studies
report either no benefit or potential harm [4-9]. This discrepancy between clinical practice
and evidence reflects many factors, including the inability to reliably identify which patients
are most likely to benefit from corticosteroid prescription [10].
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Corticosteroid activity is, in part, dependent on the glucocorticoid receptor (GCR). There
exist functional polymorphisms of the GCR gene, which are associated with either increased
or decreased sensitivity to corticosteroids [11]. Among these, the minor alleles of the GCR
polymorphisms N363 (rs56149945, formerly rs6195) and BclI (rs41423247) are associated
with increased sensitivity to corticosteroids. The N363 polymorphism affects the GCR transactivating domain, whereas the BclI polymorphism is an intronic restriction length
polymorphism. Conversely, the minor allele of GCR polymorphism 9β (rs6198) is
associated with decreased sensitivity to corticosteroids. This polymorphism increases the
stability of the GCRβ splice variant, which functions as a dominant negative receptor for
corticosteroids, relative to GCRα.
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Among patients with a variety of inflammatory disorders, these functional GCR
polymorphisms have been associated with clinical outcomes and response to exogenous
corticosteroids [12-15]. Here, we conducted a candidate gene association study to test the
hypothesis that these polymorphisms are associated with outcome and corticosteroid
responsiveness among children with septic shock.

METHODS
Study Subjects
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The protocol for consenting and enrolling study subjects was approved by the Institutional
Review Board of each participating institution and was previously detailed [16, 17]. Briefly,
children ≤ 10 years of age admitted to the pediatric intensive care unit (PICU) and meeting
pediatric-specific consensus criteria for septic shock were eligible for enrollment [18]. There
were no exclusion criteria, other than the inability to obtain informed consent. After
informed consent from the parents or legal guardians, blood samples for DNA isolation and
clinical data were collected. Clinical and laboratory data were collected daily while in the
PICU. The protocol for coding corticosteroid exposure was previously detailed [5]. Organ
failure data were tracked up to day seven of septic shock using published criteria [18].
Mortality was tracked for 28 days after enrollment. Illness severity was estimated using the
PRISM III score [19]. Control subjects consisted of critically ill children meeting criteria for
systemic inflammatory response syndrome (PICU controls) and healthy children presenting
to the ambulatory department for screening laboratory studies [17].
Genotyping
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The three polymorphisms of interest were detected using polymerase chain reaction (PCR)
technology and a QuantStudio™ 6 instrument (ThermoFisher Scientific, Waltham, MA).
Taqman PCR primers and Taqman genotyping master mix were purchased from Applied
Biosystems, ThermoFisher Scientific. Genotype calls were made using Applied Biosystems
TaqMan Genotyper Software.
Data Analysis
Initially, data are described using medians, interquartile ranges, frequencies, and
percentages. Comparisons between groups used ANOVA on Ranks or the Chi-square test as
appropriate. Descriptive statistics and comparisons used SigmaStat Software (Systat
Software, Inc., San Jose, CA).
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For testing the association between genotype and outcome we grouped the patients with
septic shock into four genotype groups: 1) those with at least one allele associated with
increased sensitivity to corticosteroids (rs56149945 or rs41423247); 2) those with at least
one allele associated with decreased sensitivity to corticosteroids (rs6198); 3) those with a
mixture of increased and decreased sensitivity alleles; and 4) those homozygous for the wild
type allele. The primary outcome variable was complicated course, defined as the
persistence of two or more organ failures at day seven of septic shock or 28-day mortality
[6]. We used logistic regression to test for an association between corticosteroid exposure
and complicated course, within genotype group, and adjusted for PRISM III score.
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RESULTS
The three polymorphisms were in Hardy-Weinberg equilibrium. The allele frequencies were
not different when comparing subjects with septic shock (n = 482) to healthy controls (n =
49) and PICU controls (n = 103) (data not shown). Table 1 shows the demographic and
clinical data for the subjects with septic shock, grouped according to the GCR alleles. There
was no difference in the rate of complicated course among the four groups (p = 0.267, Chisquare, 3 degrees of freedom). The proportion of subjects with gram-negative bacteria was
different across the four groups, as was the proportion of Caucasian and African-American
subjects. No other differences were noted.
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Table 2 shows the results of logistic regression testing for an association between
corticosteroid exposure and complicated course, within each allele group. Among all
subjects, corticosteroids were not associated with complicated course. Among subjects who
were homozygous for the wild type GCR allele, exposure to corticosteroids was
independently associated with increased odds of complicated course. This association
remained when also accounting for age and the presence of co-morbidity (O.R. 2.32; 95%
C.I. 1.01 to 5.34; p = 0.047). Corticosteroids exposure was not associated with outcome
among the other GCR allele groups.

DISCUSSION
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In 2002, Annane et al. published a landmark study indicating that a corticotropin stimulation
test and the corresponding blood cortisol concentrations could identify a subgroup of
patients with septic shock most likely to benefit from corticosteroids [20]. The results were
not replicated in a subsequent study [21], suggesting that the information provided by
corticotropin stimulation test is not sufficient to consistently select patients who are more
likely to benefit from corticosteroids and that other factors affect corticosteroid
responsiveness among patient with septic shock. Indeed, critically ill patients demonstrate
significant variability with regard to cortisol metabolism and GCR expression, and among
critically ill children, a polymorphism in the corticotropin receptor gene was associated with
a blunted cortisol response [22-25].
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In the current study, we explored three functional GCR polymorphisms and tested their
association with outcome and corticosteroid responsiveness. None of the polymorphisms
was associated with outcome or corticosteroid responsiveness, as measured by the rate of
complicated course. However, among patients who were homozygous for the wild type
allele, corticosteroid exposure was associated with increased risk of complicated course,
after adjusting for illness severity.
Collectively, the data suggest that corticosteroids might be harmful for children with septic
shock who are homozygous for the GCR wild type allele, relative to the polymorphisms
examined in the current study. This assertion must be interpreted with caution because we
conducted a candidate association study, and consequently did not test all of the existing
GCR polymorphisms. Further, the number of patients in the decreased and mixed sensitivity
allele groups was relatively small. We did not conduct a priori power calculations, which is a
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characteristic of a well conducted gene association study [26]. This reflects a lack of prior
data linking these polymorphisms to pediatric sepsis outcomes on which to base power
calculations. It is therefore possible that we were underpowered to detect an association
between the gene variants and complicated course. We note, however, that the number of
patients in the current study is greater than that of prior studies with positive findings, albeit
in adults and conditions other than sepsis [13, 14].
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Corticosteroid prescription was not protocolized, thus raising the possibility of confounding
by variability in patient care, inconsistent indications for corticosteroid prescription, and
illness severity. We note, however, that the association between outcomes, corticosteroid
prescription, and homozygosity for the wild type allele persisted after adjustments for illness
severity, age, and the presence of co-morbidity. Nonetheless, our study also did not detect
any benefit of corticosteroids in this cohort, thus strengthening the appeal for equipoise on
the subject pending a randomized controlled trial of corticosteroids in pediatric septic shock.

Acknowledgments
Funding: Supported by the National Institutes of Health (R01GM099773 and R01GM108025).

REFERENCES

Author Manuscript
Author Manuscript

1. Menon K, McNally JD, Choong K, et al. A survey of stated physician practices and beliefs on the
use of steroids in pediatric fluid and/or vasoactive infusion-dependent shock. Pediatr Crit Care Med.
2013; 14(5):462–466. [PubMed: 23628832]
2. Hanna W, Wong HR. Pediatric sepsis: challenges and adjunctive therapies. Crit Care Clin. 2013;
29(2):203–222. [PubMed: 23537672]
3. Menon K, Wong HR. Corticosteroids in Pediatric Shock: A Call to Arms. Pediatr Crit Care Med.
2015; 16(8):e313–317. [PubMed: 26226342]
4. Menon K, McNally D, Choong K, et al. A systematic review and meta-analysis on the effect of
steroids in pediatric shock. Pediatr Crit Care Med. 2013; 14(5):474–480. [PubMed: 23867428]
5. Atkinson SJ, Cvijanovich NZ, Thomas NJ, et al. Corticosteroids and pediatric septic shock
outcomes: a risk stratified analysis. PLoS One. 2014; 9(11):e112702. [PubMed: 25386653]
6. Wong HR, Cvijanovich NZ, Anas N, et al. Developing a clinically feasible personalized medicine
approach to pediatric septic shock. Am J Respir Crit Care Med. 2015; 191(3):309–315. [PubMed:
25489881]
7. Wong HR, Cvijanovich NZ, Allen GL, et al. Corticosteroids are associated with repression of
adaptive immunity gene programs in pediatric septic shock. Am J Respir Crit Care Med. 2014;
189(8):940–946. [PubMed: 24650276]
8. Zimmerman JJ, Williams MD. Adjunctive corticosteroid therapy in pediatric severe sepsis:
observations from the RESOLVE study. Pediatr Crit Care Med. 2011; 12(1):2–8. [PubMed:
20228689]
9. Markovitz BP, Goodman DM, Watson RS, et al. A retrospective cohort study of prognostic factors
associated with outcome in pediatric severe sepsis: what is the role of steroids? Pediatr Crit Care
Med. 2005; 6(3):270–274. [PubMed: 15857523]
10. Atkinson SJ, Wong HR. Identifying critically ill patients who may benefit from adjunctive
corticosteroids: not as easy as we thought. Pediatr Crit Care Med. 2014; 15(8):769–771. [PubMed:
25280145]
11. Quax RA, Manenschijn L, Koper JW, et al. Glucocorticoid sensitivity in health and disease. Nat
Rev Endocrinology. 2013; 9(11):670–686. [PubMed: 24080732]

Pediatr Crit Care Med. Author manuscript; available in PMC 2018 April 01.

Cvijanovich et al.

Page 6

Author Manuscript
Author Manuscript
Author Manuscript

12. van Oosten MJ, Dolhain RJ, Koper JW, et al. Polymorphisms in the glucocorticoid receptor gene
that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis. Arthr Res Ther.
2010; 12(4):R159. [PubMed: 20727199]
13. van Rossum EF, Koper JW, Huizenga NA, et al. A polymorphism in the glucocorticoid receptor
gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and
cholesterol levels. Diabetes. 2002; 51(10):3128–3134. [PubMed: 12351458]
14. van Rossum EF, Feelders RA, van den Beld AW, et al. Association of the ER22/23EK
polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in
elderly men. Am J Med. 2004; 117(3):158–162. [PubMed: 15276593]
15. Quax RA, Koper JW, Huisman AM, et al. Polymorphisms in the glucocorticoid receptor gene and
in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to
glucocorticoid bridging therapy in rheumatoid arthritis. Rheumatol Int. 2015; 35(8):1325–1333.
[PubMed: 25724472]
16. Wong HR, Shanley TP, Sakthivel B, et al. Genome-level expression profiles in pediatric septic
shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics. 2007;
30(2):146–155. [PubMed: 17374846]
17. Wong HR, Cvijanovich N, Allen GL, et al. Genomic expression profiling across the pediatric
systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med.
2009; 37(5):1558–1566. [PubMed: 19325468]
18. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions
for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6(1):2–8. [PubMed:
15636651]
19. Pollack MM, Patel KM, Ruttimann UE. The Pediatric Risk of Mortality III--Acute Physiology
Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care
unit patients. J Pediatr. 1997; 131(4):575–581. [PubMed: 9386662]
20. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and
fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288(7):862–871.
[PubMed: 12186604]
21. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl
J Med. 2008; 358(2):111–124. [PubMed: 18184957]
22. Boonen E, Vervenne H, Meersseman P, et al. Reduced cortisol metabolism during critical illness. N
Engl J Med. 2013; 368(16):1477–1488. [PubMed: 23506003]
23. Shibata AR, Troster EJ, Wong HR. Glucocorticoid Receptor Expression in Peripheral WBCs of
Critically Ill Children. Pediatr Crit Care Med. 2015; 16(5):e132–140. [PubMed: 25850866]
24. van den Akker EL, Koper JW, Joosten K, de Jong FH, Hazelzet JA, Lamberts SW, HokkenKoelega AC. Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of
children with sepsis. Intensive Care Med. 2009; 35(7):1247–1254. [PubMed: 19373457]
25. Jardine D, Emond M, Meert KL, Harrison R, Carcillo JA, Anand KJ, Berger J, Newth CJ, Willson
DF, Nicholson C, et al. A single nucleotide polymorphism in the corticotropin receptor gene is
associated with a blunted cortisol response during pediatric critical illness. Pediatr Crit Care Med.
2014; 15(8):698–705. [PubMed: 25055195]
26. Stalets E, Wong HR. Critically associating. Crit Care Med. 2009; 37(4):1492–1493. [PubMed:
19318832]

Author Manuscript
Pediatr Crit Care Med. Author manuscript; available in PMC 2018 April 01.

Cvijanovich et al.

Page 7

Table 1

Author Manuscript

Demographic and clinical data for the patients with septic shock, based on allele groups.
Variable

Increased
Sensitivity
Allele

N
Complicated Course, n (%)

Decreased
Sensitivity
Allele

Mixed Increased
and Decreased
Sensitivity Alleles

Homozygous
for the Wild
Type Allele

227

50

60

145

64 (28)

8 (16)

19 (32)

38 (26)

Mortality, n (%)

23 (10)

2 (4)

7 (12)

16 (11)

Maximum number of organ
failures, median (IQR)

2 (2 – 3)

2 (1 – 2)

2 (2 – 3)

2 (2 – 3)

PICU length of stay, median

8 (3 – 14)

6 (4 – 9)

7 (3 – 12)

9 (4 – 16)

PICU free days, median (IQR)

19 (9 – 24)

22 (18 – 24)

21 (9 – 25)

18 (8 – 24)

PRISM, median (IQR)

a

days (IQR)
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12 (7 – 19)

11 (9 – 17)

11 (8 – 15)

12 (7 – 18)

Age, median years (IQR)

3 (1 – 7)

3 (2 – 8)

5 (1 – 8)

3 (1 – 7)

Males, n (%)

135 (59)

25 (50)

36 (60)

84 (56)

Co-morbidity, n (%)

93 (41)

22 (44)

28 (47)

65 (45)

Malignancy, n (%)

21 (9)

7 (14)

6 (10)

13 (9)

Immunesuppression, n (%)

23 (10)

7 (14)

6 (10)

18 (12)

Bone marrow transplant, n (%)

10 (4)

1 (2)

3 (5)

5 (3)

101 (44)

32 (64)

31 (52)

75 (52)

46 (20)

8 (16)

8 (13)

49 (34)

Gram positive bacteria, n (%)

62 (27)

14 (28)

13 (22)

34 (23)

Other organism, n (%)

26 (11)

5 (10)

9 (15)

14 (10)

Culture negative, n (%)

93 (41)

23 (46)

30 (50)

48 (33)

172 (76)

45 (90)

55 (92)

79 (54)

28 (12)

1 (2)

1 (2)

37 (26)

Asian

3 (1)

2 (4)

0 (0)

7 (5)

Other

11 (5)

0 (0)

1 (2)

14 (10)

Unreported

13 (6)

2 (4)

3 (5)

8 (6)

Corticosteroids, n (%)

b

Gram negative bacteria, n (%)

Race, n (%)
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Caucasian

b

African American

b

a

Includes survivors only.

b

p < 0.05, Chi-square, 3 degrees of freedom.
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Logistic regression testing the association between corticosteroid exposure and complicated course within
each GCR allele group.
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Genotype Group

Variable

O.R.

95% CI

P value

All subjects

Corticosteroids
PRISM

1.33
1.09

0.87 – 2.05
1.06 – 1.12

0.190
<0.001

Increased sensitivity allele

Corticosteroids
PRISM

1.34
1.09

0.72 – 2.49
1.05 – 1.13

0.356
<0.001

Decreased sensitivity allele

Corticosteroids
PRISM

0.78
1.14

0.14 – 4.29
1.02 – 1.28

0.778
0.027

Mixed sensitivity alleles

Corticosteroids
PRISM

0.75
1.07

0.26 – 2.30
0.99 – 1.16

0.614
0.101

Homozygous, wild type allele

Corticosteroids
PRISM

2.30
1.09

1.01 – 5.21
1.04 – 1.14

0.047
<0.001
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